STEAP2 and hepatocellular carcinoma: In conclusion, our data suggest that STEAP2 contributes to HCC progression by increasing copper absorption in hepatocytes, activating stress-activated MAPK pathways JNK and p38, and inducing migration and invasion in HCC cells.